An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Patients Treated With the Abbott TriClip™ Device (bRIGHT)
Sponsored by Abbott Medical Devices
About this trial
Last updated 2 years ago
Study ID
ABT-CIP-10317
Status
Active, not recruiting
Type
Observational
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Started 5 years ago
What is this trial about?
The bRIGHT EU PAS study is an observational real-world study evaluating severe tricuspid
regurgitation patients treated with the Abbott TriClip™ device (bRIGHT EU Post-Approval
Study).
What are the participation requirements?
Inclusion Criteria
1. Subjects (>=18 years age) have severe tricuspid regurgitation and are symptomatic despite medical therapy.
2. Subjects eligible to receive the TriClip™ per the current approved Indications for Use.
3. Subject must provide written informed consent prior to study procedure.
Exclusion Criteria
1. Subjects participating in another clinical study that may impact the follow-up or results of this study.